I've had the same question since the topline announcement - what are the Lymphocyte Counts / CD49d results?I originally thought the following highlighted section of the topline announcement referred to the quality-of-life assessment.I'm now thinking this point is referring to the Lymphocyte Counts / CD49d results. The Phase II announcement from December 2019 included a table of statistics with comments referring to trending significantly lower.
The ongoing administration of the drug over the 24 weeks you would expect to see a trend form for lower Lymphocyte Counts / CD49d. But the recent topline announcement indicates no trend.Agree, more to this story.
I've had the same question since the topline announcement - what...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $10.87M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3790595 | 1.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.0¢ | 466666 | 3 |
View Market Depth
| Last trade - 10.04am 25/06/2025 (20 minute delay) ? |
| PER (ASX) Chart |
Day chart unavailable